Modeling and simulation of a low-grade urinary bladder carcinoma

Computers in Biology and Medicine

Volumn 58, Issue , 2015, Pages 118-129

  Bunimovich Mendrazitsky, Svetlana ^a   Pisarev, Vladimir ^b,c,d   Kashdan, Eugene ^e  

^a ARIEL UNIVERSITY   (Israel)

^b V A NEGOVSKY RESEARCH INSTITUTE OF GENERAL REANIMATOLOGY   (Russian Federation)

^c FSI Federal Research and Clinical Center of Children Hematology Oncology and Immunology of Roszdrav   (Russian Federation)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Angiogenesis; Bladder cancer; Cellular automata; Hybrid model; Nonlinear diffusion absorption equation

Indexed keywords

CARCINOGENS; CELLULAR AUTOMATA; DIFFUSION; DIFFUSION IN GASES; DISEASES; GENE EXPRESSION; OXYGEN; TUMORS;

ANGIOGENESIS; BLADDER CANCERS; CONTINUOUS PROCESS; HISTOLOGICAL STRUCTURE; HYBRID MODEL; MEDICAL LITERATURES; MODEL AND SIMULATION; NONLINEAR DIFFUSION;

NONLINEAR EQUATIONS;

CARCINOGEN;

ABSORPTION; ANGIOGENESIS; APOPTOSIS; ARTICLE; BASAL CELL; BLADDER CARCINOMA; BLADDER POLYP; BLADDER TUMOR; CANCER CELL; CANCER GRADING; CANCER STEM CELL; CARCINOMA IN SITU; CELL DEATH; CELL HYPOXIA; CELL PROLIFERATION; CONTINUOUS PROCESS; DAUGHTER CELL; DIAGNOSTIC ERROR; HUMAN; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; OXYGEN CONCENTRATION; OXYGEN DIFFUSION; OXYGEN TRANSPORT; POLYP; PRIORITY JOURNAL; TUMOR GROWTH; UROTHELIUM; BIOLOGICAL MODEL; BIOLOGY; BLADDER; COMPUTER SIMULATION; CYTOLOGY; NONLINEAR SYSTEM; PHYSIOLOGY;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84922344469     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2014.12.022     Document Type: Article

References (68)

1. Jemal A., et al. Global cancer statistics. CA: A Cancer J. Clin. 2011, 61:69-90.
2. Burger M., et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 2013, 63(2):234-241.
3. Kashdan E., Bunimovich-Mendrazitsky S. Multi-scale model of bladder cancer development. Discret. Contin. Dyn. Syst. Suppl. 2011, 803-812.
4. Swanson K.R., Alvord E.C., Murray J.D. A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif. 2000, 33:317-329.
5. Byrne H.M., et al. Modelling the response of vascular tumours to chemotherapy. a multiscale approach. Math. Models Methods Appl. Sci. 2006, 16:1219-1241.
6. Kashdan E., Bunimovich-Mendrazitsky S. Hybrid discrete-continuous model of invasive bladder cancer. Math. Biosci. Eng. 2013, 10:729-742.
7. V. Kumar, A.K. Abbas, N. Fausto, Robbins and Cotran Pathological Basis of Disease, 7th ed. Elsevier, Philadelphia, 2005 (Chapter 21).
8. Shier D., Butler J., Lewis R. Hole[U+05F3]s Human Anatomy and Physiology 2012, McGraw-Hill, New York. 13th ed.
9. Woodroffe P.J., et al. Modelling cell signalling and differentiation in the urothelium. Bull. Math. Biol. 2005, 67:369-389.
10. Ho P.L., Kurtova A., Chan K.S. Normal and neoplastic urothelial stem cells. getting to the root of the problem. Nat. Rev. Urol. 2012, 9(10):583-594.
11. Shin K., et al. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat. Cell Biol. 2014, 16(5):469-478.
12. Adamowicz J., et al. The relationship of cancer stem cells in urological cancers. Cent. Eur. J. Urol. 2013, 66(3):273-280.
13. Staack A., et al. Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration. Differentiation 2005, 73:121-133.
14. Eble J.N., Young R.H. Carcinoma of the urinary bladder. a review of its diverse morphology. Semin. Diagn. Pathol. 1997, 14(2):98-108.
15. Hassen W., Droller M.J. Current concepts in assessment and treatment of bladder cancer. Curr. Opin. Urol. 2000, 10:291-299.
16. George B., Datar R.H., Cote R.J. Molecular biology of bladder cancer. cell cycle alterations. Textbook of Bladder Cancer 2006, 107-122. Taylor and Francis, Boca Raton, Florida. S.P. Lerner, M.P. Schoenberg, C.N. Sternberg (Eds.).
17. Knowles M.A. Molecular subtypes of bladder cancer. Jekyll and Hyde or chalk and cheese? Review. Carcinogenesis 2006, 27(3):361-373.
18. Brandau S., Böhle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur. Urol. 2001, 39:491-497.
19. J.H. Guth, The mechanism of asbestos-induced carcinogenesis: calcium and plasma membrane integrity, in: Proceedings of the 59th Meeting of Virginia Academy of Sciences, Norfolk, VA, 1981.
20. Theodorescu D. Molecular pathogenesis of urothelial bladder cancer. Histol. Histopathol. 2003, 18:259-274.
21. Tokar E.J., Benbrahim-Tallaa L., Waalkes M.O. Metal ions in human cancer development. Met. Ions Life Sci. 2011, 8:375-401.
22. Eblin K.E., Bredfeldt T.G., Gandolfi A.J. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer. Toxicology 2008, 248(2-3):67-76.
23. Yang M. A current global view of environmental and occupational cancers. J. Environ. Sci. Health C 2011, 29(3):223-249.
24. Beyersmann D. Effects of carcinogenic metals on gene expression. Toxicol. Lett. 2002, 127(1-3):63-68.
25. Somji S., et al. Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As(+3)- and Cd(+2)-induced bladder cancer. Cell Biol. Toxicol. 2011, 27(6):381-396.
26. Carpenter R.L., Jiang B.H. Roles of EGFR, PI3K, AKT, and mTOR in heavy metal-induced cancer. Curr. Cancer Drug Targets 2013, 13(3):252-266.
27. Feki-Tounsi M., et al. Trace metal quantification in bladder biopsies from tumoral lesions of Tunisian cancer and controls subjects. Environ. Sci. Pollut. Res. Int. 2014, 21(19):11433-11438.
28. Cazier J.B., et al. Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden. Nat. Commun. 2014, 5:3756.
29. Alarcon T., Byrne H.M., Maini P.K. A cellular automaton model for tumour growth in inhomogeneous environment. J. Theor. Biol. 2003, 225:257-274.
30. Transitional Epithelium of the Urinary Bladder. 〈〉. Image available for use under CCA license. http://en.wikipedia.org/wiki/Urothelium.
31. Klein A.M., Simons B.D. Universal patterns of stem cell fate in cycling adult tissues. Development 2011, 138:3103-3111.
32. Gaisa N.T., et al. The human urothelium consists of multiple clonal units, each maintained by a stem cell. J. Pathol. 2011, 225:163-171.
33. Shin K., et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 2011, 472(7341):110-114.
34. B. Alberts, et al., Molecular Biology of the Cell, Garland Science, New York, 5th ed., 2008 (Chapter 17).
35. Durinck S., et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011, 1:137-143.
36. Pellettieri J., Sanchez Alvarado A. Cell turnover and adult tissue homeostasis. from humans to planarians. Annu. Rev. Genet. 2007, 41:83-105.
37. J. Southgate, et al., Urothelial tissue regulation, in: S. Baskin, S.W. Hayward (Eds.), Advances in Bladder Research, vol. 462, 1999, pp. 19-30.
38. Kinzler K.W., Vogelstein B. Life (and death) in a malignant tumour. Nature 1996, 379:19-20.
39. Fellous T.G., McDonald S.A., Burkert J. A methodological approach to tracing cell lineage in human epithelial tissues. Stem Cells 2009, 27:1410-1420.
40. Wnek S.M., et al. Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid. Toxicol. Appl. Pharmacol. 2009, 241:202-209.
41. Royds J.A., et al. Response of tumour cells to hypoxia. role of p53 and NFkB. J. Clin. Pathol.: Mol. Pathol. 1998, 51:55-61.
42. Naumov G.N., et al. A model of human tumor dormancy. an angiogenic switch from the nonangiogenic phenotype. J. Natl. Cancer Inst. 2006, 98(5):316-325.
43. Sagol O., Yorukoglu K., Sis B. Does angiogenesis predict recurrence in superficial transitional cellcarcinoma of the bladder?. Urology 2001, 57:895-899.
44. Vasquez J.L. Porous Medium Equation. Mathematical Theory 2007, Oxford University Press, Oxford.
45. Shishkov A., Veron L. The balance between diffusion and absorption in semilinear parabolic equations. Rend. Lincei-Mat. Appl. 2007, 18:59-96.
46. Hemstreet G.P., Messing E.M. Early detection for bladder cancer. Textbook of Bladder Cancer 2006, 257-266. Taylor and Francis, Boca Raton, Florida. S.P. Lerner, M.P. Schoenberg, C.N. Sternberg (Eds.).
47. Vandivier R.W., Henson P.M., Douglas J.S. Burying the dead*. the impact of failed apoptotic cellremoval (efferocytosis) on chronic inflammatory lung disease. CHEST 2006, 129(6):1673-1682.
48. U.S. EPA. Guidelines for Exposure Assessment. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC, EPA/600/Z-92/001, 1992.
49. Folkman J. Tumor angiogenesis. therapeutic implications. N. Engl. J. Med. 1971, 285:1182-1186.
50. Aebersold D.M., Burri P., Beer K.T. Expression of hypoxia-inducible factor-1α. a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 2001, 61:2911-2916.
51. Jones A., Fujiyama C., Blanche C. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor 1-α and hypoxia-inducible factor 2-α in human bladder tumors and cell lines. Clin. Cancer Res. 2001, 7:1263-1272.
52. Turner S., Sherratt J.A. Intercellular adhesion and cancer invasion. a discrete simulation using the extended potts model. J. Theor. Biol. 2002, 216(1):85-100.
53. Bugge T., et al. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood 1997, 90(11):4522-4531.
54. Prior B.M., Yang H.T., Terjung R.L. What makes vessels grow with exercise training?. J. Appl. Physiol. 2004, 97(3):1119-1128.
55. Hillen F., Griffioen A.W. Tumour vascularization. sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007, 26(3-4):489-502.
56. US EPA, Risk Assessment Guidance for Superfund (RAGS) Part A 〈〉 (Chapter 7). http://www.epa.gov/oswer/riskassessment/ragsa.
57. Patel A.A., et al. A cellular automaton model of early tumor growth and invasion. J Theor. Biol. 2001, 213(3):315-331.
58. Neumann H.G. Risk assessment of chemical carcinogens and thresholds. Crit. Rev. Toxicol. 2009, 39(6):449-461.
59. Jain R.K. Transport of molecules in the tumor interstitium. a review. Cancer Res. 1987, 47:3039-3051.
60. Casciari J.J., Sotirchos S.V., Sutherland R.M. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J. Cell. Physiol. 1992, 151(2):386-394.
61. Rejniak K.A., et al. The role of tumor tissue architecture in treatment penetration and efficacy. an integrative study. Front. Oncol. 2013, 3:1-13.
62. Truskey G.A., Yuan F., Katz D.F. Transport Phenomena in Biological Systems 2009, Prentice Hall, Upper Saddle River, New Jersey. 2nd ed.
63. Valabérgue R., et al. Relation between cerebral blood flow and metabolism explained by a model of oxygen exchange. J. Cereb. Blood Flow Metabol. 2003, 23:536-545.
64. Florescu A., et al. Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke. focus on developmental toxicology. Ther. Drug Monitor. 2009, 31(1):14-30.
65. E. Kashdan, ERWIN-High-Order Accurate Parallel Solver for Multidimensional Systems of Time-Dependent Nonlinear PDEs, Technical Report, School of Mathematical Sciences, Tel Aviv University, 2009.
66. Cheng L., Bock B.J., Bostwick D.G. Urinary Bladder. Essentials of Anatomic Pathology 2002, Humana Press, Totowa, New Jersey, (Chapter 25). L. Cheng, D.G. Bostwick (Eds.).
67. Mitra A.P., Datar R.H., Cote R.J. Molecular pathways in invasive bladder cancer. new insights into mechanisms, progression, and target identification. J. Clin. Oncol. 2006, 24(35):5552-5564.
68. Bates A.W., Baithun S.I. The significance of secondary neoplasms of the urinary and male genital tract. Virchows Arch. 2002, 440:640-647.